'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, Transocean, and DuPont. Here's the science behind the Los Angeles wildfires ...
After stocks slumped during a volatile first session of the year, CNBC's JimCramer suggested ... if we simply keep getting more money going into index funds," Cramer said. "That's what really ...